Publications
Detailed Information
Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, H | - |
dc.contributor.author | Jung, YK | - |
dc.contributor.author | Park, OJ | - |
dc.contributor.author | Lee, YJ | - |
dc.contributor.author | Choi, JY | - |
dc.contributor.author | Choi, YN | - |
dc.date.accessioned | 2023-04-19T07:06:37Z | - |
dc.date.available | 2023-04-19T07:06:37Z | - |
dc.date.created | 2021-04-14 | - |
dc.date.created | 2021-04-14 | - |
dc.date.issued | 2005-12 | - |
dc.identifier.citation | Journal of Immunology, Vol.175 No.11, pp.7193-7201 | - |
dc.identifier.issn | 0022-1767 | - |
dc.identifier.uri | https://hdl.handle.net/10371/190797 | - |
dc.description.abstract | We incidentally found that osteoclast precursors and mature osteoclasts express Fas ligand (FasL) as well as Fas, which was confirmed by flow cytometry, immunofluorescent staining, and RT-PCR. The aim of this study was to determine the role of FasL in differentiation and cell death of osteoclasts. To study the role of FasL in osteoclastogenesis, neutralizing anti-FasL mAb or rFasL was added during receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis using bone marrow-derived macrophages. Neutralization of endogenous FasL by anti-FasL mAb decreased osteoclastogenesis, whereas rFasL enhanced osteoclast differentiation in a dose-dependent manner. In addition, rFasL up-regulated the secretion of osteoclastogentic cytokines, such as IL-1 beta and TNF-alpha, and the activation of NF-kappa B. Functional blocking of IL-beta and TNF-a using IL-1 receptor antagonist and soluble TNFR confirmed that those cytokines mediated the effect of FasL on osteoclastogenesis. The osteoclast precursors were relatively resistant to rFasL-induced apoptosis especially before RANKL treatment, resulting in minimal cell loss by rFasL treatment during osteoclastogenesis. Although rFasL increased the cell death of mature osteoclasts, growth factor withdrawal induced much more cell death. However, anti-FasL mAb did not affect the survival of mature osteoclasts, suggesting that the endogenous FasL does not have a role in the apoptosis of osteoclasts. Finally, in contrast to the effect on apoptosis, rFasL-assisted osteoclastogenesis was not mediated by caspases. In conclusion, FasL has a novel function in bone homeostasis by enhancing the differentiation of osteoclasts, which was not considered previously. | - |
dc.language | 영어 | - |
dc.publisher | American Association of Immunologists | - |
dc.title | Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis | - |
dc.type | Article | - |
dc.identifier.doi | 10.4049/jimmunol.175.11.7193 | - |
dc.citation.journaltitle | Journal of Immunology | - |
dc.identifier.wosid | 000233544200017 | - |
dc.identifier.scopusid | 2-s2.0-28244491672 | - |
dc.citation.endpage | 7201 | - |
dc.citation.number | 11 | - |
dc.citation.startpage | 7193 | - |
dc.citation.volume | 175 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Choi, YN | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | COLONY-STIMULATING FACTOR | - |
dc.subject.keywordPlus | INTERFERON-GAMMA | - |
dc.subject.keywordPlus | CELL-DEATH | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | OSTEOPROTEGERIN | - |
dc.subject.keywordPlus | SECRETION | - |
dc.subject.keywordPlus | CYTOKINE | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.